A Study of Pembrolizumab in Combination With Investigational Agents in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01B/LIGHTBEAM-U01)
Clinical trial NCT06395090 · WITHDRAWN
Trial details
- NCT number
- NCT06395090
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-15
- Primary completion
- 2029-06-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.